Publications by authors named "Sem Geertsema"

Claim this Profile
E
Elevated serum glutathione reflects endoscopic disease activity in inflammatory bowel disease.
Sem Geertsema, Hannah J Holstein, Marian L C Bulthuis, Sofie de Jong, Marjan Reinders-Luinge

Free Radic Biol Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum peroxiredoxin-4, a biomarker of oxidative stress, associates with new-onset chronic kidney disease: A population-based cohort study.
Sem Geertsema, Paul Geertsema, Lyanne M Kieneker, Amaal E Abdulle, Sacha la Bastide-van Gemert

Redox Biol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Serum Free Thiols in Inflammatory Bowel Disease: Contribution of Albumin to Extracellular Free Thiol Status.
Arno R Bourgonje, Sem Geertsema, Hannah J Holstein, Marian L C Bulthuis, Gerard Dijkstra

Inflamm Bowel Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-18 Inhibition in Inflammatory Bowel Disease: A Delicate Balance.
Sem Geertsema, Raphael R Fagundes, Antonius T Otten, Gerard Dijkstra, Klaas Nico Faber

Inflamm Bowel Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unsuitability of the Oxidation-Reduction Potential Measurement for the Quantification of Fecal Redox Status in Inflammatory Bowel Disease.
Sem Geertsema, Bernadien H Jansen, Harry van Goor, Gerard Dijkstra, Klaas Nico Faber

Biomedicines· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease.
Sem Geertsema, Arno R Bourgonje, Raphael R Fagundes, Ranko Gacesa, Rinse K Weersma

Trends Mol Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: disentangling the role of redox-active compounds in the development of inflammatory bowel diseases - moving towards causal associations.
Sem Geertsema, Harry van Goor, Gerard Dijkstra, Klaas Nico Faber, Arno R Bourgonje

Aliment Pharmacol Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases.
Sem Geertsema, Antonius T Otten, Dianne G Bouwknegt, Marijn C Visschedijk, Arno R Bourgonje

Inflamm Bowel Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent Cholecystitis Due to Gallstone Obstruction of a Lumen-Apposing Metal Stent.
Sem Geertsema, Rob J Meinds, Niels G Venneman

Clin Gastroenterol Hepatol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis